A friendly debate held at the European Hematology Association 2023 Congress focused on the potential for real-world data to improve the generalizability of clinical trial results but also acknowledged ...

In this exclusive video ahead of the upcoming American Society of Hematology annual meeting, Vijay G. Sankaran, MD, PhD, of Boston Children's Hospital, previews a multidisciplinary session on how ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, ...

Our fellowship program is dedicated to advancing the art and science of medicine through a rich and diverse educational experience at top-flight academic medical centers. The program is a ...

Patient centricity is too frequently used as a buzzword in a grand vision statement or keynote address — so often that it can lose its meaning. For me, it is more than that. It is a credo that guides ...

Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

Please provide your email address to receive an email when new articles are posted on . More representation of women as study participants occurred in trials with female vs. male leadership.

Please provide your email address to receive an email when new articles are posted on . Clinical trial accrual rates have dropped 20% since the start of the COVID-19 pandemic, poll results showed.

COLUMBUS, Ohio & VENTURA, Calif.--(BUSINESS WIRE)--Deep Lens and Ventura County Hematology Oncology Specialists today announced that they have entered into a strategic agreement that will expand ...

Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical ...

Welcome to the Regeneron conference call to discuss its Factor XI development program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this ...

Director, Sickle Cell Disease and Iron Overload Program, Fred Hutch Assistant Professor, Division of Hematology and Oncology, University of Washington School of Medicine Personalized care is very ...